Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Galectin 9 (LGALS9) is a soluble beta‑galactoside‑binding lectin encoded by the LGALS9 gene, distributed within intracellular compartments and also released into extracellular tissue microenvironments via non‑canonical secretory routes. Distinct from integral transmembrane receptors, LGALS9 lacks lipid‑anchoring transmembrane segments and membrane‑embedded signaling domains, and is confirmed to operate as a soluble lectin that interacts with beta‑galactose‑containing glycan moieties under basal physiological conditions. Unbalanced glycan‑driven molecular interactions readily accumulate without sufficient soluble lectin modulatory factors, and LGALS9 tends to deliver moderate molecular buffering to sustain balanced glycan‑mediated cell communication across diverse tissue niches. Different tissue compartments generate distinct glycoprotein profiles, requiring diversified soluble lectin pools to maintain overall immune signal equilibrium within multicellular tissue systems. Freely diffused LGALS9 might continuously bind glycan‑bearing surface partners to restrain aberrant glycan‑driven signal outputs and preserve steady local immune balance.
Variants of the LGALS9 gene might alter glycan‑binding affinity and correlate with rearranged tissue immune profiles, and no other galectin paralog fully reproduces the dual capacity of LGALS9 for dual‑domain glycan recognition and extracellular immune modulation. Shifts in LGALS9 expression levels likely align with local immune activation status, rendering it a suitable research subject for soluble lectin and glycan‑immune crosstalk analysis. LGALS9 resides in aqueous intracellular and extracellular spaces rather than lipid bilayers, binds glycan‑modified protein partners without initiating transmembrane signaling cascades; its fully soluble localization separates it from membrane‑bound effector molecules, carrying dual potential to stabilize glycan‑driven intercellular communication and mediate reversible cell‑surface molecular contacts. Diminished functional LGALS9 could disturb glycan‑mediated cell‑cell interaction and weaken local immune signal buffering capacity, further validating research value for fundamental soluble galectin studies.
Fig. 1 Schematic classification of the galectin superfamily. LGALS9 (Galectin‑9) belongs to the tandem‑repeat subfamily, possessing two carbohydrate‑recognition domains linked by a flexible peptide. Monomer structures and oligomerization modes for three galectin subgroups are presented.1
The biological functions of soluble LGALS9 lectin protein are focused on sustained glycan-partner capture and intercellular immune signal coordination:
Creative Biolabs offers purified LGALS9 protein samples produced under unified preparation workflows, including full-length LGALS9 constructs and isolated single carbohydrate-recognition-domain variants. Truncated domain fragments cannot sustain complete dual-domain glycan-binding behaviors, while full-length constructs suit research focused on lectin-glycan association and glycan-driven immune observation. All batches receive uniform quality screening. Functional relevant observation may only be carried out with full-length samples under simulated extracellular microenvironment setups. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length LGALS9 samples retain intact dual carbohydrate-recognition-domain conformation after standardized purification, which supports reliable detection of weak and transient lectin-glycan contacts for comparative functional analysis.
Not finding the potein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable LGALS9 expression cell research models with varied expression levels, applicable to structural observation of soluble lectins and research into glycan-partner molecular interaction. Sample evaluation includes sustained target expression detection and preliminary partner-interaction observation, enabling side-by-side comparison of lectin-binding behaviors under differing expression abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in glycan-partner capture efficiency alongside shifting target protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-LGALS9 recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for intracellular-extracellular localization mapping and identification of lectin-glycan molecular complexes. The antibody series can work alongside common laboratory detection reagents to realize multi-dimensional observation of target distribution within tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for LGALS9 research:
LGALS9 might act as a soluble beta-galactoside-binding lectin and participate in glycan-partner recognition to modulate intercellular immune communication.
LGALS9 expression status could alter glycan-mediated intercellular interaction efficiency and local immune signal intensity, serving as a major regulatory mediator of glyco-immune biological processes.
No, all LGALS9 related products and services are strictly for research use only, and cannot be applied in clinical workflows. All material designs and functional tests are optimized exclusively for basic laboratory research scenarios, without matching clinical application standards.
Offerings include full-length LGALS9 soluble protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on glycan-driven immune homeostasis and lectin-mediated cell communication.
Laboratory observation schemes may include lectin-glycan interaction related tests to analyze molecular-binding associated behaviors under simulated extracellular environments.
